🔮 Better than the Oracle? Our Fair Value found this +42% bagger 5 months before Buffett bought itRead More

Philips on course to hit profitability target as margins improve

Published 25/07/2016, 12:19
© Reuters. A Philips logo is seen at Philips headquarters in Amsterdam
AEX
-
PHG
-
LIGHT
-

By Thomas Escritt

AMSTERDAM (Reuters) - Philips (AS:PHG) is on course to hit its 2016 profitability target as it reinvents itself as a pure healthcare company, with strong growth in medical technology partially offset by the costs of heavy research and development investments.

The company's first results since spinning off the lower-margin Philips Lighting (AS:LIGHT) business, in which it still owns a 70 percent stake, hit consensus forecasts as higher volumes and tight cost control improved margins.

Adjusted earnings before interest, tax and amortisation (EBITDA) of 544 million euros (£455.3 million) compared with 534 million euros forecast by analysts.

Sales rose 3 percent to 5.9 billion euros, led by growth of 5 percent at its health technology businesses, in line with expectations, and its adjusted EBITA margin improved to 9.3 percent, against 6.8 percent in the first quarter.

Margin improvement was partially offset by investments of "tens of millions" in connected systems and healthcare informatics, Chief Executive Frans van Houten said in an interview.

Philips, which is targeting a margin of 11 percent for the full year, has said margin improvements will be "backloaded" toward the second half of the year.

Volcano, a catheter company Philips acquired last year, was showing double digit growth, van Houten said, partly as a result of combining the two companies' different sales channels.

"Cross-selling into each other's customer base is generating extra growth," he said. The company was open to further focused acquisitions, he said, with systems for processing patient data and diagnostics of particular interest.

In the personal care business, which contributes 30 percent of revenues, new connected devices were establishing closer relationships between Philips and customers, he said, citing an oxygen mask for patients with sleep problems that allowed Philips to offer them coaching through cloud computing.

He said Philips was committed to Britain, where it has a factory and is also conducting clinical trials and research and development activities, despite the country's vote last month to leave the European Union.

"We are all a bit concerned about what Brexit will involve," he said, listing presidential elections in the U.S. and the global security situation as other risk factors.

© Reuters. A Philips logo is seen at Philips headquarters in Amsterdam

Philips shares were up 2.8 percent at 24.44 euros at 1208 London time, outperforming Amsterdam's large-cap AEX index, which was up 0.49 percent.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.